CYP24A1 and Hypercalcemia: CYP24A1 mutations were first detected following reports of a small cohort of babies developing adverse effects (including hypercalcemia and nephrocalcinosis) as a result of the public health intervention to routinely supplement formula milk with vitamin D [20].